Henry Schein (HSIC) Competitors

Henry Schein (NASDAQ:HSIC) and Cardinal Health (NYSE:CAH) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, community ranking, risk, dividends, earnings, valuation, media sentiment, profitability and analyst recommendations.

Do insiders & institutionals have more ownership in HSIC or CAH?

96.6% of Henry Schein shares are held by institutional investors. Comparatively, 87.2% of Cardinal Health shares are held by institutional investors. 1.1% of Henry Schein shares are held by company insiders. Comparatively, 0.1% of Cardinal Health shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Is HSIC or CAH more profitable?

Henry Schein has a net margin of 2.51% compared to Cardinal Health's net margin of 0.56%. Henry Schein's return on equity of 12.90% beat Cardinal Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Henry Schein	2.51%	12.90%	5.21%
Cardinal Health	0.56%	-56.56%	4.13%

Does the MarketBeat Community believe in HSIC or CAH?

Cardinal Health received 541 more outperform votes than Henry Schein when rated by MarketBeat users. Likewise, 71.64% of users gave Cardinal Health an outperform vote while only 51.65% of users gave Henry Schein an outperform vote.

Company	Underperform	Outperform
Henry Schein	Outperform Votes 376 51.65%	Underperform Votes 352 48.35%
Cardinal Health	Outperform Votes 917 71.64%	Underperform Votes 363 28.36%

Does the media prefer HSIC or CAH?

In the previous week, Cardinal Health had 11 more articles in the media than Henry Schein. MarketBeat recorded 18 mentions for Cardinal Health and 7 mentions for Henry Schein. Cardinal Health's average media sentiment score of 0.93 beat Henry Schein's score of 0.64 indicating that Cardinal Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Henry Schein	3 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Cardinal Health	9 Very Positive mention(s)	2 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has preferable valuation and earnings, HSIC or CAH?

Cardinal Health has higher revenue and earnings than Henry Schein. Cardinal Health is trading at a lower price-to-earnings ratio than Henry Schein, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Henry Schein	$12.50B	0.70	$416M	$2.43	28.73
Cardinal Health	$224.45B	0.13	$852M	$5.14	23.01

Do analysts rate HSIC or CAH?

Henry Schein currently has a consensus target price of $78.89, suggesting a potential upside of 12.99%. Cardinal Health has a consensus target price of $127.50, suggesting a potential upside of 7.80%. Given Henry Schein's higher possible upside, equities analysts clearly believe Henry Schein is more favorable than Cardinal Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Henry Schein	0 Sell rating(s)	6 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.55
Cardinal Health	0 Sell rating(s)	5 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.62

Which has more volatility & risk, HSIC or CAH?

Henry Schein has a beta of 0.87, indicating that its share price is 13% less volatile than the S&P 500. Comparatively, Cardinal Health has a beta of 0.61, indicating that its share price is 39% less volatile than the S&P 500.

Summary

Henry Schein beats Cardinal Health on 10 of the 19 factors compared between the two stocks.